CN107583041A - A kind of osteoporosis calcium tablet - Google Patents

A kind of osteoporosis calcium tablet Download PDF

Info

Publication number
CN107583041A
CN107583041A CN201710826570.XA CN201710826570A CN107583041A CN 107583041 A CN107583041 A CN 107583041A CN 201710826570 A CN201710826570 A CN 201710826570A CN 107583041 A CN107583041 A CN 107583041A
Authority
CN
China
Prior art keywords
parts
calcium
bone
osteoporosis
calcium tablet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201710826570.XA
Other languages
Chinese (zh)
Inventor
钱兵荣
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nantong Rongcheng Pharmaceutical Chemical Co Ltd
Original Assignee
Nantong Rongcheng Pharmaceutical Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nantong Rongcheng Pharmaceutical Chemical Co Ltd filed Critical Nantong Rongcheng Pharmaceutical Chemical Co Ltd
Priority to CN201710826570.XA priority Critical patent/CN107583041A/en
Publication of CN107583041A publication Critical patent/CN107583041A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention discloses a kind of osteoporosis calcium tablet, the calcium tablet by weight, including following component:20 30 parts of bone calcium powder, 10 20 parts of ossein, 10 20 parts of plant extracts, 5 10 parts of vitamin, 26 parts of chondroitin sulfate, 24 parts of microcrystalline cellulose, 8 16 parts of sodium carboxymethyl starch, 28 parts of pilose antler, 37 parts of jujube, 38 parts of ginseng, 5 10 parts of glucose.It the advantage is that:Promote the absorption of calcium in the present invention with bone calcium powder, the ossein that the bone amount that supplement mid-aged population occurs with aging is lost in addition adds deposition of the calcium in bone, strengthens sclerotin, can repair cartilage, improve osteoporosis;Collagen calcium tablet of the present invention aims at the elderly and designed, with strong points, can be effectively improved middle-aged and old osteoporosises, reach the healthcare function for increasing middle-aged and old bone densities.

Description

A kind of osteoporosis calcium tablet
Technical field
The invention belongs to pharmaceutical technology field, and in particular to a kind of osteoporosis calcium tablet.
Background technology
Calcium is the important element of human life, is Source of life, is the mainstay for ensureing people's health, once Calcareous deficiency, body will be unable to normal operation.Once it is calcareous insufficient, can be drawn from skeleton, human body daily from sweat and Discharged in urine it is internal calcareous, these be consumed it is calcareous also must go to supplement from the nutrition of every daily ingestion, to reach body The calcareous balance of body.If it is unable to the intake deficiency of calcium, it will trigger osteoporosis.Osteoporosis is a kind of clinical normal One of bone disease seen, it is that one kind is changed in quality with Low BMD and bone tissue fine structure, destroyed and causes the increase of bone fragility, bone density Reduce, and easily cause metabolic bone disease of the fracture for principal character.Osteoporosis appears in person in middle and old age more, seriously endangers The health of the elderly.With Future population aging aggravation, middle-aged and old osteoporosises and its may bring one Series Health problem particularly merits attention.
It has been topic that people often talk about to replenish the calcium, and is that common dosage is larger using calcium carbonate in existing technology of replenishing the calcium One of calcium supplementing product, calcareous reasonable, effective supplement is closely related with the prevention and treatment of osteoporosis.The supplement of blindness Calcium agent, the effect not necessarily obtained.
The content of the invention
In view of the above-mentioned deficiencies in the prior art, it is an object of the present invention to now provide a kind of good absorbing effect, can replenish the calcium and can The osteoporosis calcium tablet of pre- anti-osteoporosis.
In order to solve the above technical problems, the technical solution adopted by the present invention is:A kind of osteoporosis calcium tablet, its innovative point It is:The calcium tablet by weight, including following component:Bone calcium powder 20-30 parts, ossein 10-20 parts, plant extracts 10-20 parts, vitamin 5-10 parts, chondroitin sulfate 2-6 parts, microcrystalline cellulose 2-4 parts, sodium carboxymethyl starch 8-16 parts, pilose antler 2-8 parts, jujube 3-7 parts, ginseng 3-8 parts, glucose 5-10 parts.
Further, the glucose is one kind in manganese gluconate or copper gluconate.
Further, the plant extracts be Rhizoma Drynariae, Radix Codonopsis, Radix Angelicae Sinensis, it is windproof in one or more.
Beneficial effects of the present invention are as follows:Promote the absorption of calcium in the present invention with bone calcium powder, supplement mid-aged population companion The ossein that the bone amount occurred with aging is lost in addition adds deposition of the calcium in bone, strengthens sclerotin, can repair soft Bone, improve osteoporosis;Collagen calcium tablet of the present invention aims at the elderly and designed, with strong points, can effectively change It is apt to middle-aged and old osteoporosises, reaches the healthcare function for increasing middle-aged and old bone densities.
Embodiment
Embodiments of the present invention are illustrated by particular specific embodiment below, those skilled in the art can be by this explanation Content disclosed by book understands other advantages and effect of the present invention easily.
Embodiment 1
A kind of osteoporosis calcium tablet, calcium tablet by weight, including following component:20 parts of bone calcium powder, 10 parts of ossein, bone are broken Piao 10 parts, 5 parts of vitamin, 2 parts of chondroitin sulfate, 2 parts of microcrystalline cellulose, 8 parts of sodium carboxymethyl starch, 2 parts of pilose antler, 3 parts of jujube, 3 parts of ginseng, 5 parts of manganese gluconate.
Embodiment 2
A kind of osteoporosis calcium tablet, calcium tablet by weight, including following component:30 parts of bone calcium powder, 20 parts of ossein, Radix Codonopsis 20 parts, 10 parts of vitamin, 6 parts of chondroitin sulfate, 4 parts of microcrystalline cellulose, 16 parts of sodium carboxymethyl starch, 8 parts of pilose antler, 7 parts of jujube, 8 parts of ginseng, 10 parts of copper gluconate.
Embodiment 3
A kind of osteoporosis calcium tablet, calcium tablet by weight, including following component:25 parts of bone calcium powder, 15 parts of ossein, Radix Angelicae Sinensis With windproof 15 parts, it is 7 parts of vitamin, 4 parts of chondroitin sulfate, 3 parts of microcrystalline cellulose, 12 parts of sodium carboxymethyl starch, 5 parts of pilose antler, red 5 parts of jujube, 5 parts of ginseng, 7 parts of manganese gluconate.
Promote the absorption of calcium, the bone amount stream that supplement mid-aged population occurs with aging in the present invention with bone calcium powder The ossein for losing addition adds deposition of the calcium in bone, strengthens sclerotin, can repair cartilage, improves osteoporosis;Institute of the present invention State collagen calcium tablet and aim at the elderly and design, it is with strong points, middle-aged and old osteoporosises can be effectively improved, reach increasing Add the healthcare function of middle-aged and old bone densities.
Above-described embodiment is presently preferred embodiments of the present invention, is not the limitation to technical solution of the present invention, as long as The technical scheme that can be realized on the basis of above-described embodiment without creative work, it is regarded as falling into patent of the present invention Rights protection scope in.

Claims (3)

  1. A kind of 1. osteoporosis calcium tablet, it is characterised in that:The calcium tablet by weight, including following component:Bone calcium powder 20- 30 parts, ossein 10-20 parts, plant extracts 10-20 parts, vitamin 5-10 parts, chondroitin sulfate 2-6 parts, microcrystalline cellulose 2-4 parts, sodium carboxymethyl starch 8-16 parts, pilose antler 2-8 parts, jujube 3-7 parts, ginseng 3-8 parts, glucose 5-10 parts.
  2. A kind of 2. osteoporosis calcium tablet according to claim 1, it is characterised in that:The glucose is manganese gluconate Or one kind in copper gluconate.
  3. A kind of 3. osteoporosis calcium tablet according to claim 1, it is characterised in that:The plant extracts is that bone is broken Piao, Radix Codonopsis, Radix Angelicae Sinensis, it is windproof in one or more.
CN201710826570.XA 2017-09-14 2017-09-14 A kind of osteoporosis calcium tablet Pending CN107583041A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710826570.XA CN107583041A (en) 2017-09-14 2017-09-14 A kind of osteoporosis calcium tablet

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710826570.XA CN107583041A (en) 2017-09-14 2017-09-14 A kind of osteoporosis calcium tablet

Publications (1)

Publication Number Publication Date
CN107583041A true CN107583041A (en) 2018-01-16

Family

ID=61052068

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710826570.XA Pending CN107583041A (en) 2017-09-14 2017-09-14 A kind of osteoporosis calcium tablet

Country Status (1)

Country Link
CN (1) CN107583041A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111135284A (en) * 2019-12-11 2020-05-12 武汉跃莱健康产业有限公司 Composition for improving bone mineral density and preparation method and application thereof
CN111729030A (en) * 2020-08-11 2020-10-02 阮树月 Compound bone collagen and preparation method thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1836704A (en) * 2005-03-24 2006-09-27 刘智伟 Nutritious calcium tablet
CN1903360A (en) * 2006-08-18 2007-01-31 孙天民 Calcium-tablet for preventing osteoporosis
CN102949710A (en) * 2012-05-08 2013-03-06 北京润康普瑞生物技术有限公司 Pharmaceutical composition or healthcare product for increasing bone mineral density and preparation method of pharmaceutical composition or healthcare product
CN105903003A (en) * 2016-05-05 2016-08-31 中国人民解放军第306医院 Composition for improving disuse osteoporosis and application of composition

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1836704A (en) * 2005-03-24 2006-09-27 刘智伟 Nutritious calcium tablet
CN1903360A (en) * 2006-08-18 2007-01-31 孙天民 Calcium-tablet for preventing osteoporosis
CN102949710A (en) * 2012-05-08 2013-03-06 北京润康普瑞生物技术有限公司 Pharmaceutical composition or healthcare product for increasing bone mineral density and preparation method of pharmaceutical composition or healthcare product
CN105903003A (en) * 2016-05-05 2016-08-31 中国人民解放军第306医院 Composition for improving disuse osteoporosis and application of composition

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111135284A (en) * 2019-12-11 2020-05-12 武汉跃莱健康产业有限公司 Composition for improving bone mineral density and preparation method and application thereof
CN111729030A (en) * 2020-08-11 2020-10-02 阮树月 Compound bone collagen and preparation method thereof

Similar Documents

Publication Publication Date Title
CN103340400A (en) Food with functions of enhancing immunity, supplementing calcium and anti-aging
CN101433625A (en) Compound trepang glycopeptide oral liquid
CN107583041A (en) A kind of osteoporosis calcium tablet
CN103720903A (en) Anti-inflammation lung-clearing and liver-protecting tea and preparation method thereof
CN101129660A (en) Medicament for treating chronic obstructive emphysema and chronic pulmonary heart disease
CN104083636A (en) Immunity enhancement dendrobium officinale composition and preparation method thereof
CN105999130A (en) Traditional Chinese medicinal composition for treating insomnia, and preparation method thereof
CN105029568A (en) Black garlic beverage and preparation method thereof
CN106075343A (en) A kind of blood fat reducing Chinese-western medicine preparation and preparation method thereof
CN102406808A (en) Traditional Chinese medicine composition for treating thoracic obstruction
CN104644821A (en) Traditional Chinese medicine fat-reduction oral administration composition
CN1839929A (en) Chinese traditional compound formulation for protecting liver
CN102961673A (en) Medicine for alleviating hangover
CN111196982A (en) Mulberry compound wine
CN1846771A (en) Spot-eliminating and physique strengthening composition
CN1491589A (en) Disease-proof health drink and its producing process
CN107184810A (en) A kind of whitening spot-removing Chinese medicinal mask powder
CN103599431A (en) Traditional Chinese medicine formula for treating cardiac asthma
CN103341132B (en) Anti-malarial medicine capsule and preparation method thereof
CN102919438B (en) Hongyan tea and method for making same
CN102145085A (en) Traditional Chinese medicinal health-care tea for preventing and treating hyperlipemia
CN100364559C (en) Method for preparing oral liquid of several micron powders for reducing blood sugar and anti-fatigue
CN106261299A (en) A kind of Mel Kiwi fruit juice beverage
CN101461938A (en) Preparation for treating flat wart and preparation method thereof
CN103655733A (en) Traditional Chinese medicine composition with blood pressure reducing function

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20180116

WD01 Invention patent application deemed withdrawn after publication